Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Sona Nanotech Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1010)
•••
Post by shoosh22on Jun 10, 2020 8:15am
204 Views
Post# 31132199

Sona/Cytiva/Avacta/DNC - Webinar June 17th

Sona/Cytiva/Avacta/DNC - Webinar June 17thNothinButTime posted this on Ceo.ca.  A great find.   A webinar is scheduled for June 17th to discuss Lateral Flow Tech and Covid 19.   A lot of us have tried to figure out the connection between Cytiva "formerly GEHealth", Sona & Avacta.  So many dots to connect.  This webinar will be very exciting to maybe get answers.  I really like the idea of these companies collaborating to bring Lateral Flow Technology to the forefront.  

June 17th a week today... Now more tea leaves..When is the NR going to drop..  I would think before so Darren can speak openly... I don't think he would take part in a Webinar if the test was still being validated...  IMHO.  

https://www.labroots.com/webinar/panel-discussion-critical-design-considerations-covid-19-rapid-poc-diagnostic-test-development

Thanks NothinButTime for htis beauty find..          GLTA
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities